Role of Kinins in the Renal Response to Enalaprilat in Normotensive and Hypertensive Rats
- 1 February 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 27 (2) , 235-244
- https://doi.org/10.1161/01.hyp.27.2.235
Abstract
Abstract This study examined the role of endogenous kinins in the alteration of renal hemodynamics induced by low-dose converting enzyme inhibition in hydropenic normotensive rats and in the nonclipped kidney of hydropenic two-kidney, one clip hypertensive rats. Infusion of a bradykinin B 2 receptor antagonist ( d- Arg 0 ,[Hyp 3 ,Thi 5,8 , d- Phe 7 ]-bradykinin, 1 or 10 μg · kg −1 · min −1 ) did not alter renal function of normotensive rats. In a second series of experiments, infusion of enalaprilat at 0.1 mg · kg −1 · h −1 increased renal blood flow ( P <.01) and decreased renal vascular resistance ( P <.01). The superimposition of the kinin antagonist at 1 μg · kg −1 · min −1 during the enalaprilat infusion decreased renal blood flow to a value similar to the preenalaprilat baseline and significantly different from the mean of the two enalaprilat periods before and after the addition of the kinin antagonist—the “mean effect of enalaprilat.” The decrease in renal blood flow induced by the kinin antagonist was associated with an increase in renal vascular resistance above the mean effect of enalaprilat ( P <.025). In two-kidney, one clip hypertensive rats, systemic infusion of enalaprilat augmented the hemodynamics of the nonclipped kidney by a degree similar to that in normotensive rats. In contrast to normotensive rats, superimposition of the kinin antagonist did not alter the enalaprilat-induced change in blood flow or vascular resistance of the nonclipped kidney. The results of this study suggest that endogenous kinins contribute to the increased renal function induced by low-dose converting enzyme inhibition in hydropenic normotensive rats but appear to contribute less to the enalaprilat-induced alterations of renal function in the nonclipped kidney of two-kidney, one clip hypertensive rats.Keywords
This publication has 27 references indexed in Scilit:
- Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.Hypertension, 1994
- Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibitionKidney International, 1993
- Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.Hypertension, 1991
- Kinin contribution to renal vasodilator effect of captopril in rabbit.Hypertension, 1991
- Sino-American collaboration in biomedical research and training: American and Chinese physiological societies look toward new horizonsAmerican Journal of Physiology-Cell Physiology, 1991
- Bradykinin contribution to renal blood flow effect of angiotensin converting enzyme inhibitor in the conscious sodium-restricted dog.Circulation Research, 1990
- Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins.Hypertension, 1989
- Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivoKidney International, 1987
- Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levelsThe American Journal of Cardiology, 1982
- Angiotensin I converting enzyme.Circulation Research, 1975